We have generated rats bearing an oxytocin (OXT)-enhanced cyan fluorescent protein (eCFP) fusion transgene designed from a murine construct previously shown to be faithfully expressed in transgenic mice. In situ hybridisation histochemistry revealed that the OXT-eCFP fusion gene was expressed in the supraoptic (SON) and the paraventricular nuclei (PVN) in these rats. The 5 fluorescence emanating from eCFP was observed only in the SON, the PVN, the internal layer of the median eminence (ME) and the posterior pituitary (PP). In in vitro preparations, freshly dissociated cells from the SON and axon terminals showed clear eCFP fluorescence. Immunohistochemistry for OXT and arginine vasopressin (AVP) revealed that the eCFP fluorescence co-localises with OXT-immunofluorescence, but not with 10 AVP-immunofluorescence in the SON and the PVN. Although the expression levels of the OXT-eCFP fusion gene in the SON and the PVN showed a wide range of variation in transgenic rats, eCFP fluorescence was markedly increased in the SON and the PVN, but decreased in the PP after chronic salt loading. The expression of the OXT gene was significantly increased in the SON and the PVN after chronic salt loading in both non-transgenic and transgenic rats. 15 Page 4 of 49 5
Introduction
The neurohypophyseal hormones arginine vasopressin (AVP) and oxytocin (OXT) are mainly synthesised in discrete groups of magnocellular neurosecretory cells (MNCs) located in the hypothalamus. The gene expression, synthesis and secretion of OXT and AVP in the hypothalamo-neurohypophyseal system (HNS) have been well studied, and this system is an 5 excellent model to investigate the fundamental regulation and functions of the neuroendocrine systems (Burbach et al.2001) .
Recently, transgenic animals have been widely used in the field of neuroendocrinology to understand both the physiological roles and the regulation of the neurohypophyseal hormones (Murphy & Wells 2003 , Young & Gainer 2003 . For example, we have described the generation 10 and characterisation of rats that faithfully express an AVP-enhanced green fluorescent protein (eGFP) fusion transgene (AVP-eGFP; Ueta et al. 2005) . In these rats, eGFP fluorescence was observed in the supraoptic nucleus (SON), the suprachiasmatic nucleus (SCN), the paraventricular nucleus (PVN), the median eminence (ME) and in their axon terminals in the posterior pituitary (PP) under euhydrated conditions (Ueta et al. 2005) . The level of AVP-eGFP 15 7 fusion gene expression was markedly increased after dehydration and chronic salt loading in the SON and PVN, but not the SCN (Ueta et al. 2005 , Fujio et al. 2006 . It is very interesting to note that, compared to the endogenous AVP gene, the response of the fusion gene to physiological stimuli such as osmotic challenge (Ueta et al. 2005 , Fujio et al. 2006 , stressful (Shibata et al. 2007 ) and other conditions (Ueta et al. 2008 , Suzuki et al. 2009 ) was 5 exaggerated.
Another important HNS hormone is OXT, which is mainly expressed in a different set of MCNs from AVP (Burbach et al. 2001) . The characteristics of OXT synthesising and secreting cells, and the release of OXT under different physiological conditions have widely been studied (Cazalis et al. 1985 , Dayanithi et al. 1986 , 2000 , 2008 , Ludwig et al. 2002 . Young et al. (1999) 10 have previously described OXT gene regulatory sequences capable of directing the expression of GFP to mouse OXT neurones and terminals (Young et al. 1999 , Zhang et al. 2002 . Based on these data, we have now generated transgenic rats to visualise OXT-producing MNCs and terminals using a fusion gene consisting of OXT regulatory and coding sequences in frame with an enhanced cyan fluorescent protein (eCFP), one of the various GFP spectral variants 15 8 (Hadjantonakis & Nagy 2001) . In these rats we have studied physiological responses to osmotic stimulation.
Materials and Methods
Animals 5
Non-transgenic and heterozygous transgenic Wistar rats were bred and housed under normal laboratory conditions (12-h light, 12-h dark cycle, 0700-1900 lights on) with free access to food and drinking water. All experimental procedures in this study were performed in accordance with guidelines on the use and care of laboratory animals as set out by the Physiological Society of Japan and under the control of the Ethics Committee of Animal Care 10 and Experimentation, University of Occupational and Environmental Health, Japan. For fluorescent microscopic observation for eCFP fluorescence, in situ hybridisation histochemistry for eCFP, OXT and AVP mRNAs, and analysis in plasma under normal conditions and after chronic salt loading, 1-3 months-old OXT-eCFP transgenic and control non-transgenic age-matched male and female rats were used. 15
Constructs for microinjection
In the OXT-eCFP transgene, the eCFP coding region is in frame in the middle of exon III, after the OXT and bulk of the neurophysin coding regions (Fig. 1A; Young et al. 1999 , Zhang et al. 2002 . A HincII-SphI fragment containing the nucleotide region -471 to 1640 of the mouse 5 OXT gene from plasmid VPOT8.3p2 was ligated into a modified multiple cloning region of pSP72 (Promega) at the HincII-SphI sites. A second polylinker was placed into the exon III of the OXT gene at nucleotide positions 756-766 using Eco47III and PflMI. The SmaI-NotI fragment of eCFP was inserted into the second multiple cloning region using Eco47III and NotI, placing eCFP at the end of the coding region (Young et al. 1999) . 10
The OXT-eCFP fusion gene was validated by sequencing. The transgene fragment was microinjected into the pronuclei of fertilized oocytes obtained from Wistar rats. The transgenic founders were identified by Southern blot analysis using genomic tail DNA with a 32 P-labeled eCFP probe. The founders were bred and F1 rats were screened by PCR analysis of genomic DNA extracted from the rats' tails. The PCR was performed using the oligonucleotide primers 15 10 (sense sequence: 5'-CAC CAT CTT CTT CAA GGA CGA C-3' and antisense sequence: 5'-ATG ATA TAG ACG TTG TGG CTG TTG T-3').
Frozen and/or 4% paraformaldehyde-fixed brain sections obtained from eCFP-positive rats (F1) were observed under the fluorescence microscope (Eclipse E600, Tokyo, Nikon, Japan) with a CFP filter (Nikon, Japan) for screening whether eCFP was visually expressed in the 5 hypothalamus and pituitary gland. Fluorescent microphotographs were taken by a digital camera (COOLPIX 990, Nikon, Tokyo, Japan).
Immunohistochemistry for OXT and AVP
The animals were deeply anesthetised with sodium pentobarbital (50 mg/kg) and were 10 perfused transcardially with 0.1M phosphate buffer (PB; pH 7.4) containing heparin (1000 U/l) followed by 4% (wt/vol) paraformaldehyde. The brains were then removed and cut into three blocks. The blocks which included the hypothalamus were post fixed with the same fixative for 48 h at 4 ｡ C. The tissues were then immersed in 20% (wt/vol) sucrose in 0.1M PB for 48 h at 4 ｡ C for cryoprotection, quickly frozen using powdered dry ice and sectioned at 30 µm on a cryostat 15 (Leica CM3050, Nussloch, Germany). The sections were rinsed twice with 0.1M phosphate buffer saline (PBS) containing 0.3% (vol/vol) Triton X-100. The floating sections were incubated with a primary OXT antibody (Chemicon International, Inc., Temecula, CA, USA; diluted 1: 8,000) or AVP antibody (Chemicon International, Inc., Temecula, CA, USA; diluted 1: 8,000) for 3 d at 4 ｡ C. After washing for 20 min in 0.1M PBS solution containing 0.3% 5 (vol/vol) Triton X-100, the sections were incubated for 2 h with Alexa Fluor 546-conjugated anti-rabbit IgG (Molecular Probes, Eugene, OR; diluted 1:1,000). After final washing with 0.1M PBS, sections were mounted onto the coverglasses and coverslipped with hydrophilic mounting media (Tris-HCl containing polyvinyl alcohol and glycerol). The sections were observed under a confocal laser scanning microscope (LSM510, Carl Zeiss Co. Ltd., Jena, Germany). 10
Experimental procedures
In the first experiment, we examined the effects of chronic salt loading on eCFP fluorescence in the PVN, the SON, the ME and the PP in OXT-eCFP transgenic rats. The control group consisted of 6 OXT-eCFP animals. Unless otherwise stated, all animals used in 15 12 this study were allowed free access to tap water and dry food for 10 days. The salt-loaded OXT-eCFP group (n=6) was allowed free access to tap water and dry food for the first 5 days, and then rats were given 2% (wt/vol) salt solution instead of tap water for the next 5 days. Next, the rats were deeply anaesthetised by intraperitoneal (i.p.) administration of sodium pentobarbital (50 mg/kg). After perfusion by 4% (wt/vol) paraformaldehyde, the brains and 5 pituitaries were carefully removed.
In another set of experiments examining the effects of chronic salt loading on the expressions of the eCFP, OXT and AVP genes in the SON and PVN in OXT-eCFP transgenic rats, 12 non-transgenic males and 12 females and 12 transgenic male and 12 female rats were used. Control groups of 6 non-transgenic male and 6 female rats were maintained as described 10 earlier. The salt-loaded groups of 6 non-transgenic male and 6 female rats were allowed free access to tap water and dry food for the first 5 days, and then, for the last 5 days, 2% (wt/vol) salt solution was substituted for drinking water. Control groups of 6 OXT-eCFP transgenic male and 6 female rats were allowed free access to tap water and dry food for 10 days. The salt-loaded groups of 6 OXT-eCFP transgenic male and 6 female rats were treated accordingly 15 13 salt-loaded groups of non-transgenic rats. At the end of the experiment, rats were decapitated, and trunk blood was collected. The brains were carefully removed and frozen immediately and stored at -80 ℃ until in situ hybridisation analysis. Plasma OXT and AVP in non-transgenic and transgenic rats under normal conditions and after chronic salt loading were measured by RIA (see below). Plasma osmolality and plasma concentrations of sodium were measured by 5 conventional methods (see below).
Finally, to examine the effects of chronic salt loading on body fluid homeostasis in OXT-eCFP transgenic rats, groups of 6 non-transgenic male and 6 female rats and groups of 6 OXT-eCFP transgenic male and 6 female rats were allowed free access to tap water and dry food for the first 5 days. For the last 5 days, 2% (wt/vol) salt solution was substituted for 10 drinking water in each group. From the beginning of the observation, body weight was measured at 18h00 (every 24-h period) for each rat housed in a standard metabolic cage.
Slice preparation and dissociation of OXT-eCFP transgenic rat SON neurones
The protocol for slice preparation and the dissociation of transgenic rat SON neurons has 15 been described previously in detail (Ohbuchi et al. 2009 ). Briefly, young adult male OXT-eCFP transgenic rats (80-150 g) were killed by decapitation, and the brains were quickly and carefully removed and placed in ice-cold artificial cerebrospinal fluid containing (in mM) 124 NaCl, 5 KCl, 1.3 MgSO 4 , 1.24 KH 2 PO 4 , 2 CaCl 2 , 25.9 NaHCO 3 , and 10 glucose (297-303 mOsm/liter; pH 7.4) bubbled with 95% (vol/vol) O 2 :5% (vol/vol) CO 2 . After a block containing the 5 hypothalamus was cut from the brain, coronal slices (150 µm) containing SON were cut from the block by a vibratome-type slicer (Linearslicer Pro 7, DSK, Kyoto, Japan). The slices were carefully trimmed with a circular punch (inner diameter 1.8 mm) and stored in bubbled artificial cerebrospinal fluid at room temperature (22-24 ℃) for 1 h until they were used for enzyme digestion. Enzymatic dissociation was carried out by incubating the tissue pieces in oxygenated 10 HEPES buffered solution (HBS) containing (in mM) 140 NaCl, 5 KCl, 1.2 KH 2 PO 4 , 2 CaCl 2 , 1.2 MgCl 2 , 10 glucose, and 10 HEPES (pH 7.4) supplemented with 0.5 mg/ml of deoxyribonuclease I (Sigma) and 20 units/ml Papain for 50 min at 30 ℃. The tissues pieces were then rinsed with HBS and dissociated mechanically by fire-polished glass pipettes. The cell suspension was plated onto cover-glasses. The cover-glass containing the plated neurones 15 was placed in a glass-bottom chamber and continuously perfused with HBS at a rate of 1.5 ml/min. The cells were observed under a fluorescence microscope (Eclipse TE2000-U, Tokyo, Nikon, Japan) with a CFP filter (Nikon, Japan).
Isolation of nerve terminals from the neurohypophyses 5
Two transgenic or non-transgenic rats were used for each preparation. After decapitation with a guillotine, the neurohypophyses devoid of the pars intermedia, were taken for terminal preparation as described previously (Cazalis et al. 1987 , Ueta et al. 2005 . Briefly, after removal of the anterior and the intermediate lobe of the pituitary, the neurohypophyses were dissociated in Locke buffer that contained (in mM): 140 NaCl, 5 KCl, 1.2 MgCl 2 , 1.8 CaCl 2 , 10 glucose, 10 and 10 HEPES-Tris (pH 7.25); the osmolality was between 298 and 302 mOsml/liter. The homogenized neurohypophyses were spun at 100 x g for 1 min with the supernatant then spun at 2400 x g for 4 min. The resulting pellet was then resuspended in normal Locke buffer at 37 ℃. This preparation contained pure terminals with different diameters from 2 to 10µm (Nordmann microscope (Eclipse TE2000-U, Tokyo, Nikon, Japan) with a CFP filter (Nikon, Japan).
In situ hybridisation histochemistry for eCFP, OXT and AVP mRNAs Cryostat sections were cut into 12-µm slices and thaw mounted on gelatin / chrome alum-coated slides. The locations of the hypothalamic areas including the SON and PVN were 5 determined according to coordinates given by the rat brain atlas (Paxinos & Watson 1986) . The pituitaries were also cut into 12-µm slices and thaw mounted on gelatin / chrome alum-coated slides. 35 S 3´-end-labelled deoxyoligonucleotides complementary to transcripts encoding eCFP, OXT, and AVP were used (eCFP probe sequence: 5'-GTG CGC TCT TGG ACA TAG CCT TCG GGC ATG GCG GAC TTA A-3'; OXT probe sequence: 5'-CTC GGA GAA GGC AGA 10 CTC AGG GTC GCA GGC-3'; AVP probe sequence: 5'-CAG CTC CCG GGC TGG CCC GTC CAG CT-3'). The probe was 3´-end labeled using terminal deoxynucleotidyl transferase and [ 35 S] dATP. Each labeled probe was counted. Probe for the eCFP transcripts was labeled as 4.6 ± 0.6 × 10 5 c.p.m./µl (n=5). Probe for the OXT transcripts was labeled as 3.9 ± 0.7× 10 ５ c.p.m./ µl (n=3). Probe for the AVP transcripts was labeled as 3.8 ± 0.5 × 10 ５ c.p.m./ µl (n=3). The in situ hybridisation protocol has been described previously in detail (Ueta et al. 1995) . Briefly, sections were fixed in 4% (wt/vol) formaldehyde for 5 min and incubated in saline containing 0.25% (vol/vol) acetic anhydride and 0.1M triethanolamine for 10 min and then dehydrated, delipidated in chloroform, and partially rehydrated. Hybridisation was carried out overnight at 37 ℃ in 45 µl of hybridisation buffer under a Nescofilm (Bando Kagaku, 5
Osaka, Japan) coverslip. A total count of 1 × 10 6 c.p.m. for eCFP transcripts and 5 × 10 5 c.p.m for OXT and AVP transcripts per slide was used. After hybridisation, sections were washed for 1 h in four changes of 1 × SSC (150 mM NaCl and 15 mM sodium citrate) at 55 ℃ and for an additional 1 h in two changes of 1× SSC at room temperature. Hybridised sections including the hypothalamus were examined by autoradiography (Hyperfilm, Amersham, Bucks, UK) for 2 10 weeks for the eCFP probe, 12 h for the OXT probe and 8 h for the AVP probe. The resulting images were analyzed by computerised densitometry using a MCID imaging analyzer (Imaging Research Inc., Ontario, Canada). The mean optical densities (OD) of autoradiographs were measured by comparing it with simultaneously exposed 14 C-labelled microscale samples (Amersham) and presented in arbitrary units compared to the mean OD obtained from control rats.
RIA for OXT and AVP in plasma
Plasma concentrations of OXT and AVP were determined by RIA with specific anti-OXT and anti-AVP antiserum as described previously (Onaka & Yagi 1990) . Coefficients of inter-and 5 intra-assay variations were 10 % and 5 % for OXT, 14 % and 6 % for AVP, respectively. The minimum detection limit was 2 pg/ml for OXT and 0.5 pg/ml for AVP. Cross-reactivity of the anti-AVP antibody for OXT and that of the anti-OXT antibody for AVP are less than 0.01% (Higuchi et al. 1985) .
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Measurements of osmolality and sodium concentrations in plasma
Plasma concentrations of Na + were measured using conventional methods. The osmolalities of plasma were measured in 15µl samples using a microsample osmometer (Model 110, Fiske Associates, Norwood, MA, USA).
Statistical analysis
The mean ± SEM deviation from control (%) was calculated from the results of the in situ hybridisation histochemistry study. Each group within an experiment was compared with the control group. The results of RIA, the measurements of osmolality and sodium in plasma and body weight were also expressed as the mean ± SEM. The data were analyzed using a one-way 5 fractional ANOVA followed by a Fisher's PLSD test for multiple comparisons. The statistical significance was set at P<0.05.
Results
Production of transgenic rats 10
The purified OXT-eCFP trangene was injected into the pronuclei of 665 fertilized oocytes obtained from Wistar rat donors. A total of 45 pups were obtained. Eight transgenic founders (6 male and 2 female) were identified by Southern blot analysis using genomic tail DNA with a 32 P-labeled eCFP probe. The copy numbers of the eCFP gene were between 3 and 300. Eight founders were bred and F1 rats were screened by PCR analysis of genomic DNA extracted from 15 the rats' tails. The PCR product was identified as the band of 1.6 kbp in agarose gels. Frozen brain sections obtained from eCFP-positive rats (F1) were examined by fluorescent microscopic observation. Two lines (#88-1 and #98-3) demonstrating robust expression of eCFP in the SON and the PVN were selected for physiological experiments and breeding. The copy numbers of the eCFP gene in #88-1 and #98-3 were 3 and 300, respectively. 5
In the present study one line (#98-3) was used.
Distribution of eCFP mRNA in the central neurones system (CNS)
In situ hybridisation histochemistry revealed that eCFP mRNA was localised in the SON ( Fig. 1B, D) and the magnocellular and parvocellular divisions of the PVN (Fig. 1C, E ). There 10 was no ectopic expression of the eCFP gene elsewhere in the CNS (Fig. 1B-E) . Effects of chronic salt loading on eCFP fluorescence in the hypothalamus of OXT-eCFP transgenic rats ECFP fluorescence was observed throughout the SON ( Fig. 2A ). There were scattered 5 eCFP-expressing neurones in the parvocellular division of the PVN and abundant fluorescence of eCFP in the magnocellular division of the PVN (Fig. 2B ). In the internal layer of the ME, intense fluorescence of eCFP was also observed (Fig. 2C ). In the PP, the fluorescence of eCFP was clearly observed in the axon terminals (Fig. 2D) . After salt loading for 5 days, the fluorescence of eCFP was remarkably increased throughout the SON in OXT-eCFP transgenic 10 rats ( Fig. 2E) , and in the majority of the magnocellular neurones and several parvocellular neurones in the PVN in OXT-eCFP transgenic rats (Fig. 2F) . However, the fluorescence of eCFP was decreased in the ME and in the PP (Fig. 2G, H) .
Immunostaining for OXT and AVP
Visualisation of eCFP expression in dissociated SON neurones and nerve terminals from the 15 neurohypophyses Dissociated SON neurones and axon terminals are widely used for many physiological studies using electrophysiological, fluorescence photometry and peptide release techniques but usually the cells are identified only after the recordings are made (Dayanithi et al. 1996 , Wang et al. 1999 , Widmer et al. 2003 . Here, we have succeeded in observing eCFP expression in half 5 of the population of freshly dissociated SON neurones (Fig. 2I , J) and axon terminals (Fig. 2K , L).
Effects of chronic salt loading on the expression of the eCFP gene
There were no differences of the expression of the eCFP gene in the SON and the PVN 10 between male and female transegenic rats under normal conditions (Fig. 3A, C , E, G, I, J). After salt loading for 5 days, in the some male transgenic rats, the expression of the eCFP gene in the SON and the PVN was significantly increased (Fig. 3B, F, I, J) . Under similar salt loaded conditions, female transgenic rats did not show an increase of the expression of the eCFP gene in the SON and the PVN (Fig. 3D, H-J) . It should be noted that the expression of the eCFP 15 transgene in the SON and the PVN vary widely as determined by in situ hybridisation ( Fig. 3 A-J).
Effects of chronic salt loading on the expressions of the OXT and AVP genes in the hypothalamus of non-transgenic and transgenic rats 5
There were no differences of the expression of the OXT gene in the SON and the PVN between non-transgenic and transgenic rats under normal condition (Fig. 4A, C , E, G, I-L). After salt loading for 5 days, the expression of the OXT gene in the SON and the PVN was significantly increased in both non-transgenic and transgenic rats (Fig. 4B , D, F, H-L). There were no differences of the expression of the OXT gene in the SON and the PVN between 10 non-transgenic and transgenic rats after salt loading for 5 days (Fig. 4A-L) . No differences were observed between male and female animals studied in these conditions (Fig. 4A-L ).
There were no differences of the expression of the AVP gene in the SON and the PVN between non-transgenic and transgenic rats under normal condition ( Fig. 5A, C , E, G, I-L). After salt loading for 5 days, the expression of the AVP gene in the SON and the PVN was 15 24 significantly increased in both non-transgenic and transgenic rats (Fig. 5B , D, F, H-L). There were no differences of the expression of the AVP gene in the SON and the PVN between non-transgenic and transgenic rats after salt loading (Fig. 5A-L) . No differences were observed between male and female animals studied in these conditions ( Fig. 5A-L) .
5
Effects of chronic salt loading on plasma OXT, AVP, osmolality and Na + in non-transgenic and transgenic rats There were no differences of plasma osmolality between non-transgenic and transgenic rats under normal conditions (Fig. 6A, B) . After salt loading for 5 days, the plasma osmolality was significantly increased in both non-transgenic and transgenic rats (Fig. 6A, B) . No difference 10 was observed between male and female animals studied under these parameters. Plasma sodium concentration was not altered in either non-transgenic or transgenic rats under normal conditions (Fig. 6C, D) . However, after salt loading for 5 days, plasma sodium concentrations was significantly increased in both non-transgenic and transgenic rats (Fig. 6C, D) .
There were no differences in plasma OXT levels between non-transgenic and transgenic 15 25 rats under normal conditions (Fig. 6E, F) . After salt loading for 5 days, plasma concentrations of OXT did not change in either non-transgenic or transgenic rats (Fig. 6E, F ). There were no differences in plasma AVP levels between non-transgenic and transgenic rats under normal conditions (Fig. 6G, H) . After salt loading for 5 days, the plasma AVP concentrations were significantly increased in both non-transgenic and transgenic rats (Fig. 6G, H ). There were no 5 differences in plasma AVP concentrations between non-transgenic and transgenic rats after salt loading for 5 days (Fig. 6G, H) . No differences were observed between male and females studied in these conditions/parameters.
Discussion 10
Transgenic animals are widely used to understand the physiological role and regulation of neuroendocrine genes (Murphy & Wells 2003 , Young & Gainer 2003 . Most transgenic studies have been performed on mice, but it is the rat model that is more widely been used in physiological studies, particularly in the fields of endocrinology and neuroendocrinology. The anatomy of the rat brain is well mapped, and the structure, function, and regulatory mechanisms 15 26 of the rat CNS have been clearly defined (Young et al. 1999 (Young et al. , 2003 . internal layer of the ME and PP. In situ hybridisation histochemistry, revealed that there was no expression of the eCFP gene elsewhere in the brain at the level of the SON and the PVN 5 ( Fig.1B-E) .
We then sought to identify the specific neurochemical phenotype of the cells expressing eCFP in the hypothalamus. Using a specific antibody for OXT, we have shown that almost all OXT-containing neurones express eCFP. Conversely, in the PVN, no eCFP-expressing neurones exhibited AVP-ir ( Fig.1F-K (Yue et al. 2008) . On the other hand, the intensity of the internal layer of the ME and the PP was markedly decreased after salt loading ( Fig.2A-H) . This likely indicates that, like endogenous OXT, eCFP is released into the systemic 5 circulation. In addition, it was easy to identify, by fluorescence, single OXT-eCFP expressing cells dissociated from the SON.
Our previous studies have demonstrated that the response to physiological stimuli of the AVP-eGFP fusion gene in the SON and the PVN was exaggerated (Fujio et al. 2006 , Shibata et al. 2007 ). In the present study we also examined the effects of salt loading on the expression of 10 the OXT-eCFP fusion gene in the SON and the PVN. Unexpectedly, the expression level of the OXT-eCFP gene showed a relatively wide range both under euhydrated conditions and following salt loading (Fig. 3) . Thus, it was difficult to evaluate the response of the OXT-eCFP fusion gene in the SON and the PVN to salt loading. The reason for this remains unclear, but it may be related to the use of a murine OXT transgene (Young et al. 1999 , Zhang et al. 2002 in a 15 rat host. It is also possible that the transgene is susceptible to varying amounts of epigenetic regulation (e. g., methylation). The variability of transgene expression will limit the physiological studies such as the effect of osmotic challenge on the expression of the transgene.
In the present study, we examined whether fusion gene expression disturbed endogenous OXT gene expression, and physiological response of the transgenic rats to salt loading. The 5 results showed that transgene had no effect on host mRNA synthesis, and that expression of the eCFP gene had no effect on regulation of the endogenous OXT system in the transgenic rats under normal and salt-loaded conditions. This means that the transgenic rats are suitable substrates for physiological studies such as identification of OXT cells isolated from the hypothalamus. 10
Finally, we showed that single cells isolated from the SON have sufficient eCFP fluorescence intensity to enable their identification in an in vitro preparation. In our preparations, similar eCFP fluorescence could be observed in the isolated terminals of the neurohypophysis (Fig2. K, L). These dispersed neurone and terminal preparations have been widely used for their studies in cell-specific physiology (Lambert et al. 1994 , Dayanithi et al. 2000 , Widmer et al. 15 30 2003 . The ability to directly identify OXT neurones in these preparations will be invaluable in electrophysiological and calcium imaging studies in living cells.
In conclusion, we have generated a new transgenic rat that expresses an OXT-eCFP fusion gene in the HNS. These rats demonstrate robust fluorescence specifically in OXT-secreting neurons of the SON, the PVN and the PP. For the first time, living oxytocinergic neurones can 5 be directly identified by virtue of their inherent fluorescence.
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